Do My Children Need Genetic Testing for My Schwannoma?
At a Glance
One adult schwannoma is usually sporadic, so children usually need no genetic testing. Genetic counseling should first evaluate the parent if diagnosed at a young age, tumors are multiple or bilateral, or a disease-causing family gene change is known; children may then need targeted testing.
No, your children usually do not need genetic testing simply because you were diagnosed with a single (solitary) schwannoma. The vast majority of single schwannomas diagnosed in adulthood are sporadic (happen by chance, are isolated events, and do not typically increase the inherited risk for your family) [1].
However, in a small percentage of cases, a schwannoma can be the first sign of an underlying genetic condition, such as schwannomatosis (a group of genetic conditions, including NF2-related, SMARCB1-related, or LZTR1-related disease, that predispose people to multiple nerve tumors) [2][3]. If your care team suspects a genetic link, they will recommend evaluating you first, not your children [4][5]. The exception is if a child is already experiencing suggestive symptoms or if there is a known familial pathogenic variant, in which case the child should be evaluated independently.
Red Flags for Genetic Testing
To figure out if your tumor is truly sporadic or part of an inherited genetic condition, your doctor will look for specific clinical “red flags.” You should consider genetic counseling and testing if you meet any of the following criteria:
- Young age at diagnosis: Having a single schwannoma diagnosed at a young age—often defined as before age 25 or 30, depending on clinical guidelines and tumor location—warrants consideration for genetic counseling [1]. In one study of young patients referred for evaluation, up to 29% of those under 25 with a solitary schwannoma were found to have an underlying genetic predisposition; this link was especially high for spinal tumors compared to cranial-nerve tumors [1].
- Multiple tumors: Having more than one schwannoma, or having a schwannoma along with other specific tumors like a meningioma (a tumor on the membranes covering the brain and spinal cord) or an ependymoma [6][3].
- Tumors on both hearing nerves: Having tumors on one vestibular (balance and hearing) nerve on each side—known as bilateral vestibular schwannomas—is the hallmark sign of NF2-related schwannomatosis [7][3].
- Other specific physical signs: Experiencing unusual juvenile cataracts (early eye findings), specific skin plaques assessed by a clinician, or childhood neurologic issues [3][8].
- Family history: Having blood relatives diagnosed with NF2-related schwannomatosis, multiple schwannomas, meningiomas, or ependymomas [4]. However, the absence of a family history does not rule out a genetic condition, as genetic variants can occur spontaneously (de novo) or present differently across family members [9].
How the Testing Process Works
If you have any of the red flags above, a genetic counselor will typically recommend testing your blood or saliva. They may also suggest testing the tumor tissue itself, usually from archived tissue if you already had surgery [4]. Testing the tumor is an adjunct to blood testing; comparing both helps doctors figure out the nature of the genetic change:
- Germline (Constitutional) Variant: A genetic change is found in your blood, meaning it is present in the cells you can pass on. For many schwannomatosis conditions, which are autosomal dominant, each child has a 50% chance of inheriting the variant [10]. If this is found, a genetic counselor will discuss targeted testing and specific surveillance for your children based on when symptoms typically appear [5].
- Mosaic Variant: A genetic change is present in some, but not all, of your body’s tissues [9]. Blood testing can sometimes miss low-level mosaicism, which is why testing multiple tissues or tumor samples is helpful.
- Somatic Variant: A genetic change is found only in the tumor tissue and is not inherited.
Interpreting the Results
A genetic professional must carefully interpret your results alongside your clinical picture. If testing identifies a pathogenic variant (a confirmed disease-causing genetic change) in your blood, they will guide your family’s next steps. Sometimes, tests reveal a Variant of Uncertain Significance (VUS) (a change in the DNA whose connection to disease isn’t fully understood yet). A VUS cannot be used to make medical decisions or to direct testing for your children.
If your blood test is negative, or if a variant is confirmed to be strictly somatic (only in the tumor), children usually do not need testing [9][1]. However, because tests have limitations and can occasionally miss mosaicism or unknown genes, you should rely on your genetic counselor to confirm what your specific results can and cannot rule out for your children.
Common questions in this guide
If I have one sporadic schwannoma, are my children at higher genetic risk?
What features suggest that my schwannoma may be part of an inherited condition?
Should I have genetic testing before my children do?
Why might doctors test the schwannoma as well as my blood or saliva?
What does a negative blood test mean for my children’s risk?
If a disease-causing gene change is found in my blood, should my children be tested?
Appointments are short. Make every minute count.
Specialist visits move fast. Let us help you prep so your time goes to what matters.
Testing for children
Would my children need genetic testing if a genetic link is suspected in me?
Genetic counseling
What red flags would lead to genetic counseling and testing for me?
Interpreting results
What would a negative blood test mean for my children, and what could it still miss?
Related questions
Get notified when new evidence is published on Benign schwannoma.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (10)
- 1
Association of Genetic Predisposition With Solitary Schwannoma or Meningioma in Children and Young Adults.
Pathmanaban ON, Sadler KV, Kamaly-Asl ID, et al.
JAMA neurology 2017; (74(9)):1123-1129 doi:10.1001/jamaneurol.2017.1406.
PMID: 28759666 - 2
ERN GENTURIS clinical practice guidelines for the diagnosis, treatment, management and surveillance of people with schwannomatosis.
Evans DG, Mostaccioli S, Pang D, et al.
European journal of human genetics : EJHG 2022; (30(7)):812-817 doi:10.1038/s41431-022-01086-x.
PMID: 35361920 - 3
Update on Cancer and Central Nervous System Tumor Surveillance in Pediatric NF2-, SMARCB1-, and LZTR1-Related Schwannomatosis.
Perrino MR, Jongmans MCJ, Tomlinson GE, et al.
Clinical cancer research : an official journal of the American Association for Cancer Research 2025; (31(8)):1400-1406 doi:10.1158/1078-0432.CCR-24-3278.
PMID: 39937237 - 4
Genetic findings in people with schwannomas who do not meet clinical diagnostic criteria for NF2-related schwannomatosis.
Smith MJ, Perez-Becerril C, van der Meer M, et al.
Journal of medical genetics 2024; (61(11)):1011-1015 doi:10.1136/jmg-2024-110217.
PMID: 39209702 - 5
Clinical and Genetic Overview of Neurofibromatosis Type 2 (NF2).
Kim TK, Park YS, Nakagawa I
Journal of Korean Neurosurgical Society 2025; (68(3)):272-277 doi:10.3340/jkns.2025.0048.
PMID: 40090344 - 6
Oral plexiform schwannoma: A case report and relevant immunohistochemical investigation.
Sergheraert J, Zachar D, Furon V, et al.
SAGE open medical case reports 2019; (7()):2050313X19838184 doi:10.1177/2050313X19838184.
PMID: 30911392 - 7
Genomics of vestibular schwannoma.
Smith MJ, Messiaen LM, Evans DG
Handbook of clinical neurology 2025; (212()):59-67 doi:10.1016/B978-0-12-824534-7.00023-8.
PMID: 41052866 - 8
Clinical epidemiology of NF2-related schwannomatosis.
Evans DG, Plotkin SR
Handbook of clinical neurology 2025; (212()):129-134 doi:10.1016/B978-0-12-824534-7.00013-5.
PMID: 41052833 - 9
Updated protocol for genetic testing, screening and clinical management of individuals at risk of NF2-related schwannomatosis.
Halliday D, Emmanouil B, Evans DGR
Clinical genetics 2023; (103(5)):540-552 doi:10.1111/cge.14310.
PMID: 36762955 - 10
Neurofibromatosis type 2-related schwannomatosis - An update.
Moodley M, Ortman C
Seminars in pediatric neurology 2024; (52()):101171 doi:10.1016/j.spen.2024.101171.
PMID: 39622611
This page explains when children may need genetic testing after a parent has a schwannoma for informational purposes only and does not constitute medical advice. A genetic counselor or treating clinician should interpret your family’s specific risk and testing options.